Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
Open Access
- 21 July 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (7) , 1071
Abstract
Background/Objectives: Chemotherapy-induced alopecia is a common and distressing side effect of cancer treatment, significantly impacting patients’ psychological well-being. Nanocarriers offer a promising strategy for targeted drug delivery to hair follicles, while chitosan nanoparticles have demonstrated hair-growth-promoting properties. This study explores the potential of chitosan nanoparticles as a topical delivery system for five pharmacological agents—phenobarbital, pioglitazone, rifampicin, N-acetylcysteine, and tacrolimus—to prevent chemotherapy-induced alopecia. Methods: Drug-loaded chitosan nanoparticles were prepared using the ionic gelation technique and characterized by particle size, zeta potential, entrapment efficiency, FT-IR spectroscopy, and TEM imaging. Their efficacy was assessed in a cyclophosphamide-induced alopecia model in C57BL/6 mice through macroscopic observation, histopathological examination, and scanning electron microscopy of regrown hair. Results: The prepared particles were spherical, cationic, and between 205 and 536 nm in size. The entrapment efficiencies ranged from 8% to 63%. All five drugs mitigated follicular dystrophy, shifting the hair follicle response from dystrophic catagen to dystrophic anagen. Phenobarbital demonstrated the most significant hair regrowth and quality improvements, followed by N-acetyl cysteine and pioglitazone. Tacrolimus showed moderate efficacy, while rifampicin was the least effective. Conclusions: These findings suggest that phenobarbital-loaded chitosan nanoparticles represent a promising approach for the prevention and treatment of chemotherapy-induced alopecia, warranting further investigation for clinical applications.Keywords
This publication has 151 references indexed in Scilit:
- Encapsulation of rifampin in a polymeric layer‐by‐layer structure for drug deliveryJournal of Biomedical Materials Research Part A, 2017
- The Androgenic Alopecia Protective Effects of Forsythiaside‐A and the Molecular Regulation in a Mouse ModelPhytotherapy Research, 2015
- A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictorInternational Journal of Cancer, 2014
- A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization GroupPediatric Blood & Cancer, 2012
- Promotion of Hair Growth by Rosmarinus officinalis Leaf ExtractPhytotherapy Research, 2012
- Chitosan as a barrier membrane material in periodontal tissue regenerationJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Spinning Disc Processing Technology: Potential for Large-Scale Manufacture of Chitosan NanoparticlesJournal of Pharmaceutical Sciences, 2010
- Chitosan‐NAC nanoparticles as a vehicle for nasal absorption enhancement of insulinJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2008
- Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriersJournal of Applied Polymer Science, 1997
- The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal modelsInternational Journal of Cancer, 1996